Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
NOVO HOLDINGS A/S LXEO Lexeo Therapeutics, Inc. 13G 5.1% 2y
Charles & Potomac Capital, LLC ONDS Ondas Inc. 13D/A 18.8% 2y
Daniel Kaufman HROW Harrow, Inc. 13G 5.37% 2y
George Economou SHIP Seanergy Maritime Holdings Corp. 13D 5.7% 2y
Ole Nielsen TRUP Trupanion, Inc. 13G 5.6% 2y
Ariel Emanuel TKO TKO Group Holdings, Inc. 13D 52.2% 2y
TANG CAPITAL MANAGEMENT, LLC THRX Theseus Pharmaceuticals, Inc. Common Stock 13D 7% 2y
TANG CAPITAL MANAGEMENT, LLC ACRS Aclaris Therapeutics, Inc. 13G 6.1% 2y
JAB Holdings B.V. DNUT Krispy Kreme, Inc. 13D/A 44.42% 2y
Bellevue Capital Partners, LLC NYC American Strategic Investment Co. 13D/A 46.5% 2y
René Holeček VSTO Vista Outdoor Inc. 13D/A 5.7% 2y
Farragut Square Global Master Fund, LP MRT Marti Technologies, Inc. 13D/A 13.3% 2y
KKR Asset Management LLC FSK FS KKR Capital Corp 13D/A 4.9% 2y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 16.18% 2y
Family Trading Inc. TOPS Top Ships Inc. 13D/A 63.36% 2y
Frazier Life Sciences VIII, L.P. ALPN Alpine Immune Sciences, Inc. Common Stock 13D/A 9.8% 2y
PAR Investment Partners, L.P. GRPN Groupon, Inc. 13G 19.9% 2y
Redmile Group, LLC AUGX Augmedix, Inc. Common Stock 13D/A 40.7% 2y
Saba Capital Management, L.P. NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND 13D/A 12.24% 2y
Saba Capital Management, L.P. FMN Federated Hermes Premier Municipal Income Fund 13D/A 10.54% 2y
Cannae Holdings, Inc. PSFE Paysafe Ltd 13D/A 4.77% 2y
Martin J. Wygod NSTG NanoString Technologies, Inc. 13D/A 1.49% 2y
JCP Investment Management, LLC WHG Westwood Holdings Group Inc 13D/A 5.9% 2y
Robert Arsov RUM RUM Group Inc. 13D/A 9.4% 2y
JAMES E. BESSER SNWV SANUWAVE Health, Inc. 13D/A 33.86% 2y
Goldenwise Capital Group Ltd JOB GEE Group Inc. 13D/A 4.9% 2y
GLAZER CAPITAL, LLC CCF Chase Corporation 13G/A 0% 2y
FP Credit Partners II, L.P. SATX SatixFy Communications Ltd. 13G 6.31% 2y
PharmaCyte Biotech, Inc. FEMY Femasys Inc 13D 37% 2y
Divisar Capital Management LLC SFIX Stitch Fix, Inc. 13G 5.6% 2y
Michael Singer RNAC Cartesian Therapeutics, Inc. 13D 13.9% 2y
Murat Kalayoglu RNAC Cartesian Therapeutics, Inc. 13D 19.9% 2y
Valence Investments SPV VI, LLC CALC CalciMedica, Inc. 13D/A 16.4% 2y
Venrock Healthcare Capital Partners III, L.P. ABVX Abivax S.A. 13G 5.3% 2y
VIKING GLOBAL INVESTORS LP LAB Standard Biotools Inc. 13D/A 9.5% 2y
Samsara BioCapital, L.P. KDNY Chinook Therapeutics, Inc. Common Stock 13D/A 0% 2y
VIKING GLOBAL INVESTORS LP BBIO BridgeBio Pharma, Inc. 13D/A 15.7% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 6.6% 2y
Quek Leng Chuang OIO OIO Group 13D/A 31.31% 2y
Lynrock Lake LP ALLT Allot Ltd. 13D/A 22.94% 2y
Spectrum Equity VII, L.P. GDRX GoodRx Holdings, Inc. 13D/A 31% 2y
YORKTOWN ENERGY PARTNERS IX, L.P. METC Ramaco Resources, Inc. 13D/A 11.69% 2y
Altai Capital Management, L.P. OSPN OneSpan Inc. 13D/A 4.2% 2y
Saba Capital Management, L.P. VTN Invesco Trust for Investment Grade New York Municipals 13D/A 12.01% 2y
BAKER BROS. ADVISORS LP MDGL Madrigal Pharmaceuticals, Inc. 13D/A 9.99% 2y
I.B.F Management Ltd. ADXS Advaxis, Inc. 13D/A 83.6% 2y
Yorktown Energy Partners XI, L.P. METC Ramaco Resources, Inc. 13D/A 11.64% 2y
EcoR1 Capital, LLC ATRA Atara Biotherapeutics, Inc. 13G 9.9% 2y
Mr. Bruce Flatt BNT Brookfield Wealth Solutions Ltd. 13D/A 19.99% 2y
Partners Value Investments L.P. BNT Brookfield Wealth Solutions Ltd. 13D/A 9.9% 2y